Ardelyx (ARDX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Ardelyx (ARDX) is Neutral.

The composite score behind that read is -0.06, weighing +0.14 of bullish evidence against -0.25 bearish.

Ardelyx last closed at $3.28, +0.31% on the session.

Against the IVW growth benchmark the position is -0.49% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

15 graded predictions for ARDX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Ardelyx in the 21st percentile on return on equity, where 100 is best.

Ardelyx is classified under Health Care / Biotechnology, with a market capitalisation of $814.84M.

StockMap tracks Ardelyx as the 144th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Ardelyx ranks 144th of 381 in the group, against a group median of -0.08.